https://doi.org/10.18502/ijrm.v17i2.3991
statistics
- 253 Abstract Views
- 114 PDF Views
- 0 HTML Views
- Cited by 3 articles
authors
-
Achmad Kemal Harzif
No author data available.
-
Agrifa Haloho
No author data available.
-
Melisa Silvia
No author data available.
-
Gita Pratama
No author data available.
-
Yuditiya Purwosunu
No author data available.
-
Aria Wibawa
No author data available.
-
Prijo Sidipratomo
No author data available.
-
Jacub Pandelaki
No author data available.
Published Date
- Mar 20, 2019
Trans-arterial embolization of acquired uterine arteriovenous malformation after Cesarean section: A case series
Abstract
Background: Acquired uterine arteriovenous malformation (AVM) is a rare condition due to traumatic episodes in cesarean section. The patient can suffer from life-threatening hemorrhage or recurrent vaginal bleeding. Establishing this diagnosis is difficult, often misdiagnosed due to lack of information and number of cases. Trans-Arterial Embolization (TAE) procedure is rarely performed in our center. All of the cases were found with history of massive bleeding and diagnosed lately after recurrent bleeding history. Even though promising, one of our cases failed to be managed with TAE. It is important to diagnose early symptoms of AVM in order to prevent the life-threatening event.
Case presentation: In this case series, four cases of AVMs after cesarean procedures will be reviewed. One could be diagnosed in less than a month but the other three took several months. The symptom of vaginal bleeding might occur a few weeks after the procedure is done, and most patients need transfusion and hospitalization. Three out of four patients were initially sent to the hospital in order to recover from shock condition, and one patient was sent for a diagnostic procedure. AVMs diagnostic was established with ultrasound with or without angiography. Three of our cases were succeeded by performing TAE procedure without further severe vaginal bleeding. One case failed to be treated with embolization and had to proceed with hysterectomy.
Conclusion: AVM should be considered early-on in patient with abnormal uterine bleeding and history of cesarean section. Embolization is still the first-choice treatment of AVMs, otherwise, definitive treatment is hysterectomy in a patient without fertility need, or impossible to perform TAE.
Key words: Trans-arterial embolization, Acquired uterine arteriovenous malformation, Cesarean section.
References
[2] Katimada Annaiah T, Kodakkattil Sreenivasan S. Uterine arteriovenous malformations: clinical implications. Obstet Gynaecol 2015; 17: 243–250.
[3] Moshiri M, Osman S, Bhargava P, Maximin S, Robinson TJ, Katz DS. Imaging evaluation of maternal complications associated with repeat cesarean deliveries. Radiol Clin North Am 2014; 52: 1117–1135.
[4] Scribner D, Fraser R. Diagnosis of acquired uterine arteriovenous malformation by doppler ultrasound. J Emerg Med 2016; 51: 168–171.
[5] Clarke JA, Viswanatha RK, Hamid R, Sankaranarayanan S. Diagnosis and management of life-threatening hypermenorrhagia caused by uterine arteriovenous malformation secondary to surgical termination of pregnancy: video evidence. BMJ Case Rep 2012; 2012: doi: 10.1136/bcr2012-007368.
[6] Akbayir O, Gedikbasi A, Akyol A, Ucar A, Saygi-Ozyurt S, Gulkilik A. Cesarean scar pregnancy: a rare cause
of uterine arteriovenous malformation. J Clin Ultrasound 2011; 39: 534–538.
[7] Barber Jr JT, Tressler TB, Willis GS, Martinez FJ, Peisner DB, Goodman JD, et al. Arteriovenous malformation
identification after conservative management of placenta percreta with uterine artery embolization and adjunctive therapy. Am J Obstet Gynecol 2011; 204: e4–e8.
[8] Chang KH, Park JK, Park SH, Kim HB, Park ST. Uterine arteriovenous malformation caused by intrauterine
instrumentation for laparoscopic surgery due to left tubal pregnancy. Obstet Gynecol Sci 2014; 57: 419–423.
[9] Laifer-Narin SL, Kwak E, Kim H, Hecht EM, Newhouse JH. Multimodality imaging of the postpartum or posttermination uterus: evaluation using ultrasound, computed tomography, and magnetic resonance imaging. Curr Probl Diagn Radiol 2014; 43: 374–385.[10] Rossi UG, Torcia P, Cariati M. Uterine arteriovenous malformation. Vasc Med 2016; 21: 473–474.
[11] Farias MS, Santi CC, Lima AA, Teixeira SM, De Biase TC. Radiological findings of uterine arteriovenous malformation: a case report of an unusual and life-threatening cause of abnormal vaginal bleeding. Radiol Bras 2014; 47: 122–124.
[12] Aslan H, Acar DK, Ekiz A, Kaya B, Sezer S, Ismayilzade R, et al. Sonographic features and management options of uterine arteriovenous malformation. A case report. Med Ultrason 2015; 17: 561–563.
[13] Aiyappan SK, Ranga U, Veeraiyan S. Doppler sonography and 3D CT angiography of acquired uterine arteriovenous malformations (AVMs): report of two cases. J Clin Diagn Res 2014; 8: 187–189.
[14] Akashi K, Tanno K, Chikazawa K, Mikami Y, Netsu S, Konno R. Expectant management of a case of uterine arteriovenous malformation with an ovarian artery aneurysm. J Obstet Gynaecol Res 2016; 42: 579–583.
[15] Levy-Zaubermann Y, Capmas P, Legendre G, Fernandez H. Laparoscopic management of uterine arteriovenous malformation via occlusion of internal iliac arteries. J Minim Invasive Gynecol 2012; 19: 785–788.
[16] Katano K, Takeda Y, Sugiura-Ogasawara M. Conservative therapy with a gonadotropin-releasing hormone agonist for a uterine arteriovenous malformation in a patient with congenital heart disease. Clin Case Rep 2015; 3: 479–482.
[17] Morikawa M, Yamada T, Yamada H, Minakami H. Effect of gonadotropin-releasing hormone agonist on a uterine arteriovenous malformation. Obstet Gynecol 2006; 108: 751–753.
[18] Khatree MH, Titiz H. Medical treatment of a uterine arteriovenous malformation. Aust NZ J Obstet Gynaecol
1999; 39: 378–380.
[19] Kaump GR, Spies JB. The impact of uterine artery embolization on ovarian function. J Vasc Interv Radiol
2013; 24: 459–467.